• Users Online: 217
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 3  |  Issue : 5  |  Page : 54-58

Management of hematological malignancies during the COVID-19 pandemic


1 Department of Medical Oncology, S.L. Raheja (Fortis) Hospital and HCG Hospital, Mumbai, Maharashtra, India
2 Department of Pediatrics, Mumbai and Aarya Clinic, Sterling Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Ashay Karpe
Aarya Clinic, Shop No 1, Ganjawala CHS, Near Pai Nagar Garden, Off SVP Road, Borivali (West), Mumbai - 400 092, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/CRST.CRST_123_20

Get Permissions

Coronavirus disease 2019 (COVID-19) caused by novel coronavirus, which is structurally related to the virus causing severe acute respiratory syndrome, has emerged as a global health problem. During this pandemic, treatment of oncology patients especially patients with hematological malignancies has many challenges. In the absence of definite guidelines for the management of hematological cancers, we should follow certain principles for better treatment delivery with precautions to prevent COVID-19 infection in this vulnerable population with the least compromise in patient outcome


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed160    
    Printed2    
    Emailed0    
    PDF Downloaded48    
    Comments [Add]    

Recommend this journal